Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
BR ›
BRELIANT
Trademark search for:
BRELIANT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-05-02 — Application filed
2014-05-06 — Application filed
2014-05-16 — Application filed
2014-05-31 — Assigned to examiner
2014-06-02 — Final disposition recorded
2014-06-02 — Final disposition recorded
2014-06-02 — Final disposition recorded
2014-07-08 — Assigned to examiner
2014-10-17 — Teas/email correspondence entered
2014-10-17 — Office action issued
2014-10-17 — Correspondence received in law office
2014-10-18 — Approved for pub - principal register
2014-11-04 — Assigned to lie
2014-11-12 — Law office publication review completed
2014-11-26 — Notification of notice of publication e-mailed
2014-12-16 — Published for opposition
2014-12-16 — Official gazette publication confirmation e-mailed
2015-02-10 — Noa e-mailed - sou required from applicant
2015-07-30 — Sou teas extension received
2015-07-30 — Sou extension 1 filed
2015-07-30 — Sou extension 1 granted
2015-08-01 — Notice of approval of extension request e-mailed
2016-01-08 — Sou teas extension received
2016-01-08 — Sou extension 2 filed
2016-02-12 — Case assigned to intent to use paralegal
2016-02-16 — Sou extension 2 granted
2016-02-17 — Notice of approval of extension request e-mailed
2016-07-27 — Attorney/dom.rep.revoked and/or appointed
2016-07-27 — Teas revoke/app/change addr of atty/dom rep received
2016-08-07 — Sou teas extension received
2016-08-07 — Sou extension 3 filed
2016-08-12 — Sou extension 3 granted
2016-08-13 — Notice of approval of extension request e-mailed
2017-02-09 — Sou teas extension received
2017-02-09 — Sou extension 4 granted
2017-02-09 — Sou extension 4 filed
2017-02-11 — Notice of approval of extension request e-mailed
2017-07-29 — Sou teas extension received
2017-07-29 — Sou extension 5 filed
2017-08-03 — Sou extension 5 granted
2017-08-04 — Notice of approval of extension request e-mailed
2018-03-19 — Application abandoned
2018-03-19 — Application abandoned
2018-03-19 — Final status recorded
Owner Information
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
Maury M. Tepper, III Tepper & Eyster, PLLC 3724 Benson Drive Raleigh, NC 27609 UNITED STATES
Filing Details
Filing Date:
2014-05-02
Status Date:
2018-03-19
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.